We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.05%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$7.04B
AUM Growth
-$1.16B
Cap. Flow
-$1.24B
Cap. Flow %
-17.66%
Top 10 Hldgs %
20.16%
Holding
1,770
New
124
Increased
619
Reduced
705
Closed
247

Sector Composition

Rank Sector Weight
1 Technology 19.04%
2 Financials 9.47%
3 Industrials 8.13%
4 Communication Services 7.76%
5 Healthcare 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGNG icon
1026
Global X Aging Population ETF
AGNG
$87.4M
$571K 0.01%
15,902
-384
-2% -$13.5K
EWBC icon
1027
East-West Bancorp
EWBC
$17.9B
$570K 0.01%
5,074
SBRA icon
1028
Sabra Healthcare REIT
SBRA
$5.34B
$570K 0.01%
30,070
-3,914
-12% -$72.5K
KYIV
1029
Kyivstar Group
KYIV
$3.13B
$569K 0.01%
43,832
+15,587
+55% +$205K
JGRO icon
1030
JPMorgan Active Growth ETF
JGRO
$9.37B
$567K 0.01%
6,108
+1,716
+39% +$161K
IGLD icon
1031
FT Vest Gold Strategy Target Income ETF
IGLD
$509M
$564K 0.01%
22,548
-10,605
-32% -$265K
MGK icon
1032
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
$561K 0.01%
6,800
+1,250
+23% +$103K
TLH icon
1033
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
$559K 0.01%
5,501
+2,001
+57% +$206K
CORT icon
1034
Corcept Therapeutics
CORT
$12.4B
$557K 0.01%
16,000
-2,421
-13% -$190K
NVCT icon
1035
Nuvectis Pharma
NVCT
$678M
$555K 0.01%
73,566
+4,500
+7% +$29.3K
HPQ icon
1036
HP
HPQ
$24.9B
$555K 0.01%
24,903
-3,707
-13% -$94.5K
EMQQ icon
1037
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$275M
$554K 0.01%
+13,735
New +$597K
MDST
1038
Westwood Salient Enhanced Midstream Income ETF
MDST
$285M
$551K 0.01%
+20,846
New +$543K
GAB icon
1039
Gabelli Equity Trust
GAB
$1.75B
$549K 0.01%
89,020
-25,864
-23% -$157K
HOG icon
1040
Harley-Davidson
HOG
$2.58B
$548K 0.01%
26,732
-15,106
-36% -$371K
GH icon
1041
Guardant Health
GH
$21.5B
$548K 0.01%
+5,362
New +$480K
THQ
1042
abrdn Healthcare Opportunities Fund
THQ
$777M
$546K 0.01%
28,527
+97
+0.3% +$1.78K
WFG icon
1043
West Fraser Timber
WFG
$5.08B
$544K 0.01%
8,909
-1,215
-12% -$76K
GWRE icon
1044
Guidewire Software
GWRE
$12.6B
$543K 0.01%
2,702
-129
-5% -$28.5K
TFPM icon
1045
Triple Flag Precious Metals
TFPM
$5.94B
$541K 0.01%
16,300
BAB icon
1046
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$540K 0.01%
19,849
-125
-0.6% -$3.42K
VRIG icon
1047
Invesco Variable Rate Investment Grade ETF
VRIG
$1.8B
$540K 0.01%
21,500
-10,700
-33% -$269K
RTO icon
1048
Rentokil
RTO
$11.8B
$539K 0.01%
18,298
+650
+4% +$18.1K
CAG icon
1049
Conagra Brands
CAG
$6.94B
$539K 0.01%
31,141
+5,800
+23% +$103K
IWV icon
1050
iShares Russell 3000 ETF
IWV
$19.6B
$537K 0.01%
1,389
-36
-3% -$13.8K

Similar funds

Oppenheimer & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Oppenheimer & Co held 1,770 positions worth $7.04B, down 14% from $8.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oppenheimer & Co withdrew a net $1.24B in Q4 2025, closing 247 positions and reducing 705 holdings. Its most notable exit was Apple, an estimated $286M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

Against the trend, Oppenheimer & Co opened a new position in First Trust Nasdaq Bank ETF worth $4.47M.

  • Oppenheimer & Co's largest Q4 2025 buy was First Trust Nasdaq Bank ETF: 118,163 shares worth $4.47M.
  • Oppenheimer & Co added most to iShares Russell 1000 Growth ETF in Q4 2025, an estimated $21.1M increase.
  • Oppenheimer & Co's biggest Q4 2025 reduction was ServiceTitan Inc, cutting an estimated $49.2M.
  • Oppenheimer & Co fully exited Apple in Q4 2025, selling an estimated $286M.
  • Oppenheimer & Co's ten largest holdings make up 20% of its $7.04B portfolio in Q4 2025.
  • Oppenheimer & Co opened 124 new positions and closed 247 in Q4 2025.
  • Oppenheimer & Co's portfolio value fell 14% quarter-over-quarter to $7.04B.

Based on Oppenheimer & Co's 13F filing for Q4 2025, filed 2 Feb 2026.